Peptides and Proteins
Peptides are short chains of amino acids linked by peptide bonds, whereas proteins are longer and more complex amino acid chains that can adopt functional three-dimensional structures. Both types of compounds are essential for various biological functions, such as catalysing reactions (enzymes), immune defence (antibodies), and cellular signalling. Proteins have a hierarchical structure, including the amino acid sequence, secondary, tertiary, and quaternary structures. Peptides are used in pharmaceutical and cosmetic therapies due to their specific biological properties, such as in the treatment of metabolic diseases or enhancing cellular regeneration. Proteins, on the other hand, have applications in biotechnology, nutrition, and regenerative medicine.
At CymitQuimica, we offer high-purity peptides and proteins for research in biotechnology and therapeutic applications.
Found 3118 products of "Peptides and Proteins"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Tabimorelin hemifumarate
CAS:<p>orally active ghrelin receptor (GHS-R1a) agonist</p>Formula:C32H40N403C4H404Purity:98%Color and Shape:SolidMolecular weight:586.72FK-565
CAS:<p>FK-565 is a ligand of nucleotide-binding oligomerization domain-1 (NOD1) that induces a mouse model of arteritis.</p>Formula:C22H38N4O9Color and Shape:SolidMolecular weight:502.559(S)-dHTC1
CAS:<p>(S)-dHTC1 is a molecular glue degrader specifically targeting the transcriptional coactivator ENL. It exhibits high affinity binding to E3 ligase only upon formation of the ENL:(S)-dHTC1 complex, with an IC50 of 93 nM. In MV4;11 cells, (S)-dHTC1 degrades ENL with a DC50 of 26 nM. This compound can be utilized for acute myeloid leukemia research.</p>Formula:C33H40N8O6SColor and Shape:SolidMolecular weight:676.786[Phe(Ac)]1-Octreotide (N-Acetyl-D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide cyclic (2-->7)-disulfide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C51H68N10O11S2Color and Shape:Off-White PowderMolecular weight:1060.45105[MetO8]-Teriparatide
Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C181H291N55O52S2Color and Shape:Off-White PowderMolecular weight:4131.12586[MetO8,18]-Teriparatide
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C181H291N55O53S2Color and Shape:Off-White SolidMolecular weight:4147.12077[Pro(Ac)]1-Leuprolide (5-Oxo-N-acetyl-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide)
CAS:Lactams, nesoiFormula:C61H86N16O13Color and Shape:Off-White PowderMolecular weight:1250.65603[D-His]-Leuprolide (5-Oxo-L-prolyl-D-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide)
CAS:Lactams, nesoiFormula:C59H84N16O12Color and Shape:Off-White PowderMolecular weight:1208.64546Isocyclosporin A
CAS:Lactams, nesoiFormula:C62H111N11O12Color and Shape:White Off-White PowderMolecular weight:1201.84137[O1(Ac)]8-Octreotide (D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(2R,3R)-1-acetoxy-3-hydroxybutan-2-yl]-L-cysteinamide cyclic (2-->7)-disulfide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C51H68N10O11S2Color and Shape:Off-White PowderMolecular weight:1061.28[D-Ser]-Leuprolide (5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-D-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide)
CAS:<p>Lactams, nesoi</p>Formula:C59H84N16O12Color and Shape:Off-White PowderMolecular weight:1208.64546Cyclosporin H
CAS:Lactams, nesoiFormula:C62H111N11O12Color and Shape:White Off-White SolidMolecular weight:1201.84137[L-Leu]6-Leuprolide (5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-L-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide)
CAS:<p>Lactams, nesoi</p>Formula:C59H84N16O12Color and Shape:Off-White PowderMolecular weight:1208.64546[Ser(Ac)]4-Leuprolide (5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-N-acetyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide)
CAS:Lactams, nesoiFormula:C61H86N16O13Color and Shape:Off-White PowderMolecular weight:1250.65603[Lys(Ac)]5-Octreotide (D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-N6-acetyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide cyclic (2-->7)-disulfide)
CAS:Polypeptide, protein and glycoprotein hormones, their derivatives and structural analogues, nesoiFormula:C51H68N10O11S2Color and Shape:Off-White PowderMolecular weight:1060.45105[Asp]5-Oxytocin (L-cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-aspartyl-L-cysteinyl-L-prolyl-L-leucyl-glycinamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C43H65N11O13S2Color and Shape:Off-White PowderMolecular weight:1007.42047Octreotide Acetate
CAS:<p>Polypeptide, protein and glycoprotein hormones, their derivatives and structural analogues, nesoi</p>Formula:C49H66N10O10S2·xC2H4O2Color and Shape:White PowderMolecular weight:1018.44048[MetO18]-Teriparatide
Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C181H291N55O52S2Color and Shape:Off-White PowderMolecular weight:4131.12586D-[Asp]5-Oxytocin (L-cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-D-aspartyl-L-cysteinyl-L-prolyl-L-leucyl-glycinamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C43H65N11O13S2Color and Shape:Off-White PowderMolecular weight:1007.42047[Cys(Ac)]1-Oxytocin (N-Acetyl-L-cysteinyl-L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-leucylglycinamide cyclic (1-->6)-disulfide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C45H68N12O13S2Color and Shape:Off-White PowderMolecular weight:1048.44702
